Drug:
Reaction: HOSPITALISATION
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491731 |
US |
55 | 1 |
Hospitalisation, Skin disorder, Illness, |
||||
RISANKIZUMAB-RZAA, |
||||
| 2 | 25491854 |
CN |
73 | 2 |
Hospitalisation, Disease recurrence, Dyspnoea, Chest discomfort, Abdominal distension, Pain, Discomfort, Fatigue, Drug ineffective, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 3 | 25491924 |
BR |
2 | |
Hospitalisation, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 4 | 25492024 |
JP |
||
Hospitalisation, Dysphagia, |
||||
DAPRODUSTAT, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
| 5 | 25492030 |
US |
||
Hospitalisation, |
||||
| 6 | 25492180 |
US |
56 | 1 |
Hospitalisation, |
||||
| 7 | 25492266 |
US |
69 | 2 |
Pneumonia aspiration, Sepsis, Hospitalisation, Hypertension, Hypotension, Fibromyalgia, |
||||
BETAINE, BETAINE, BETAINE, ACARBOSE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL, CLONAZEPAM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DICYCLOMINE HYDROCHLORIDE, FAMOTIDINE, FLUTICASONE PROPIONATE, GABAPENTIN, HYDROCHLOROTHIAZIDE, LACTULOSE, LOSARTAN POTASSIUM, LOSARTAN, PREGABALIN, MELOXICAM, METOCLOPRAMIDE HYDROCHLORIDE, OLANZAPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MONTELUKAST SODIUM, TIZANIDINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 8 | 25492270 |
US |
33 | 1 |
Hospitalisation, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, MODAFINIL, OLANZAPINE, |
||||
| 9 | 25492406 |
US |
||
Hospitalisation, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 10 | 25492632 |
JP |
2 | |
Hospitalisation, Pyrexia, |
||||
PEGFILGRASTIM, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 11 | 25492680 |
US |
1 | |
Hospitalisation, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 12 | 25492743 |
US |
65 | 2 |
Hospitalisation, |
||||
BELIMUMAB, BELIMUMAB, |
||||
| 13 | 25493112 |
US |
8 | 1 |
Hospitalisation, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 14 | 25493290 |
US |
2 | |
Hospitalisation, Unevaluable event, |
||||
VONOPRAZAN FUMARATE, PANTOPRAZOLE, |
||||
| 15 | 25493812 |
US |
||
Hospitalisation, |
||||
PEMBROLIZUMAB, |
||||
| 16 | 25493826 |
GB |
1 | |
Hospitalisation, Off label use, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 17 | 25493873 |
US |
37 | 1 |
Hospitalisation, Incorrect product administration duration, Product use in unapproved indication, |
||||
CHLORPHENIRAMINE MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROCHLORIDE, MELATONIN, |
||||
| 18 | 25494136 |
CA |
14 | 1 |
Coma scale abnormal, Encephalitis, Seizure, Hospitalisation, |
||||
NIVOLUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DACARBAZINE, DEXRAZOXANE FOR INJECTION, DEXRAZOXANE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 19 | 25494285 |
US |
||
Hospitalisation, |
||||
PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, |
||||
| 20 | 25494397 |
GB |
1 | |
Hospitalisation, |
||||
CLOZAPINE, |
||||
| 21 | 25494652 |
US |
||
Hospitalisation, Immunosuppression, Pneumonia, Pulmonary embolism, |
||||
UPADACITINIB, |
||||
| 22 | 25494749 |
US |
5 | 2 |
Hospitalisation, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 23 | 25494921 |
US |
2 | |
Hospitalisation, |
||||
VIGABATRIN, ERGOCALCIFEROL, FAMOTIDINE, VIGABATRIN, CLONAZEPAM, PREDNISONE, PHENOBARBITAL, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
| 24 | 25494979 |
US |
95 | 1 |
Hospitalisation, |
||||
LENALIDOMIDE, |
||||
| 25 | 25495049 |
US |
||
Hospitalisation, |
||||
| 26 | 25495119 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Accidental overdose, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Aspiration, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LORAZEPAM, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CYANOCOBALAMIN, CYANOCOBALAMIN, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ERENUMAB-AOOE, ERENUMAB-AOOE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, LANSOPRAZOLE, LANSOPRAZOLE, LISINOPRIL, LISINOPRIL, LORAZEPAM, LORAZEPAM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, FISH OIL, FISH OIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, |
||||
| 27 | 25495141 |
US |
69 | 1 |
Hospitalisation, Off label use, |
||||
POMALIDOMIDE, |
||||
| 28 | 25495261 |
DE |
89 | 2 |
Respiratory failure, Hospitalisation, |
||||
| 29 | 25495494 |
US |
30 | 2 |
Hospitalisation, |
||||
| 30 | 25495514 |
US |
74 | 1 |
Hospitalisation, Therapy interrupted, Insurance issue, |
||||
RIFAXIMIN, |
||||
| 31 | 25495550 |
CA |
2 | |
Hospitalisation, Product dose omission in error, Off label use, |
||||
PATIROMER, PATIROMER, |
||||
| 32 | 25495553 |
GB |
2 | |
Hospitalisation, Therapeutic product effect decreased, Treatment noncompliance, Antipsychotic drug level increased, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 33 | 25495559 |
US |
67 | 1 |
Hospitalisation, Incorrect dose administered, Device issue, |
||||
INSULIN GLARGINE, |
||||
| 34 | 25495582 |
US |
60 | 2 |
Hospitalisation, Weight fluctuation, |
||||
DUPILUMAB, |
||||
| 35 | 25495714 |
US |
68 | 1 |
Hospitalisation, Malaise, |
||||
DUPILUMAB, DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MONTELUKAST SODIUM, MONTELUKAST, PREDNISONE, GUAIFENESIN, |
||||
| 36 | 25495722 |
US |
78 | 2 |
Hospitalisation, Mobility decreased, Vision blurred, |
||||
INSULIN GLARGINE, |
||||
| 37 | 25496240 |
US |
1 | |
Hospitalisation, |
||||
CANNABIDIOL, |
||||
| 38 | 25496268 |
US |
1 | |
Hospitalisation, |
||||
CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, |
||||
| 39 | 25496277 |
US |
2 | |
Hospitalisation, |
||||
CANNABIDIOL, |
||||
| 40 | 25496592 |
US |
47 | 2 |
Hospitalisation, |
||||
ABATACEPT, CYCLOSPORINE, |
||||
| 41 | 25496596 |
US |
1 | |
Hospitalisation, Off label use, |
||||
CANNABIDIOL, CANNABIDIOL, |
||||
| 42 | 25496640 |
US |
2 | |
Hospitalisation, |
||||
SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MELOXICAM, ONDANSETRON HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, GABAPENTIN, |
||||
| 43 | 25496673 |
US |
66 | 2 |
Biliary obstruction, Hospitalisation, Rheumatoid arthritis, Hypoaesthesia, Paraesthesia, Dysstasia, Gait disturbance, Renal mass, |
||||
UPADACITINIB, |
||||
| 44 | 25503753 |
|||
Hospitalisation, |
||||
DASATINIB, |
||||
| 45 | 25503794 |
|||
Hospitalisation, |
||||
IMATINIB, |
||||
| 46 | 25504048 |
84 | 2 | |
Hospitalisation, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 47 | 25491488 |
GB |
2 | |
Hospitalisation, |
||||
ILOPROST, |
||||
| 48 | 25491563 |
US |
88 | 1 |
Hospitalisation, |
||||
| 49 | 25490234 |
US |
62 | 2 |
Hospitalisation, |
||||
ENASIDENIB MESYLATE, |
||||
| 50 | 25484629 |
|||
Hospitalisation, |
||||
AMBRISENTAN, EPOPROSTENOL, TREPROSTINIL, |
||||
| 51 | 25484643 |
|||
Hospitalisation, |
||||
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, TREPROSTINIL, EPOPROSTENOL, |
||||
| 52 | 25484688 |
68 | 1 | |
Hospitalisation, |
||||
AVACOPAN, |
||||
| 53 | 25486486 |
US |
2 | |
Hospitalisation, Anxiety, Insomnia, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, METHOCARBAMOL, METHOCARBAMOL TABLETS, ALBUTEROL SULFATE, ERGOCALCIFEROL, |
||||
| 54 | 25486699 |
US |
||
Hospitalisation, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 55 | 25486922 |
US |
20 | 2 |
Hospitalisation, |
||||
UPADACITINIB, |
||||
| 56 | 25487022 |
JP |
2 | |
Hospitalisation, Nephropathy, |
||||
LAMOTRIGINE, |
||||
| 57 | 25487030 |
US |
44 | 1 |
Hospitalisation, |
||||
| 58 | 25487046 |
JP |
||
Mental impairment, Hospitalisation, Refusal of treatment by patient, |
||||
DAPRODUSTAT, |
||||
| 59 | 25487100 |
JP |
||
Hospitalisation, Shunt malfunction, |
||||
DAPRODUSTAT, |
||||
| 60 | 25487234 |
JP |
||
Hospitalisation, Neoplasm malignant, |
||||
DAPRODUSTAT, |
||||
| 61 | 25487240 |
US |
||
Hospitalisation, |
||||
BEVACIZUMAB-AWWB, |
||||
| 62 | 25487498 |
BR |
1 | |
Hospitalisation, Device use issue, |
||||
FLUTICASONE FUROATE, FLUTICASONE FUROATE, |
||||
| 63 | 25487508 |
US |
||
Hospitalisation, |
||||
BOSENTAN, |
||||
| 64 | 25487727 |
US |
60 | 2 |
Hospitalisation, Oral mucosal blistering, Swelling face, Mouth swelling, Speech disorder, Unevaluable event, |
||||
LISINOPRIL, PAROXETINE HYDROCHLORIDE, AMLODIPINE, |
||||
| 65 | 25487942 |
GB |
2 | |
Hospitalisation, Malaise, |
||||
| 66 | 25487956 |
US |
61 | 1 |
Hospitalisation, |
||||
| 67 | 25488011 |
US |
73 | 1 |
Hospitalisation, |
||||
POMALIDOMIDE, |
||||
| 68 | 25488108 |
GB |
2 | |
Hospitalisation, |
||||
IVACAFTOR, |
||||
| 69 | 25488110 |
GB |
2 | |
Hospitalisation, Mental disorder, |
||||
IVACAFTOR, |
||||
| 70 | 25488119 |
CA |
1 | |
Hospitalisation, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 71 | 25488121 |
GB |
2 | |
Hospitalisation, |
||||
IVACAFTOR, |
||||
| 72 | 25488123 |
GB |
1 | |
Hospitalisation, |
||||
IVACAFTOR, |
||||
| 73 | 25488147 |
GB |
1 | |
Hospitalisation, |
||||
| 74 | 25488180 |
US |
61 | 2 |
Peripheral swelling, Pain in extremity, Skin discolouration, Lymphatic disorder, Hospitalisation, Fatigue, Asthenia, Loss of personal independence in daily activities, Influenza like illness, Fall, Condition aggravated, Urinary tract infection, Vomiting, Gait inability, Hypotonia, COVID-19, Diarrhoea, |
||||
CLADRIBINE, |
||||
| 75 | 25488210 |
JP |
||
Hospitalisation, |
||||
AVACOPAN, |
||||
| 76 | 25488488 |
CN |
2 | |
Cardiac failure, Diabetic complication, Hospitalisation, Renal disorder, |
||||
INSULIN GLARGINE, |
||||
| 77 | 25488523 |
US |
||
Hospitalisation, |
||||
VUTRISIRAN, |
||||
| 78 | 25488746 |
US |
||
Hospitalisation, Product dose omission issue, |
||||
VUTRISIRAN, |
||||
| 79 | 25488750 |
US |
||
Hospitalisation, |
||||
VUTRISIRAN, |
||||
| 80 | 25488941 |
US |
||
Hospitalisation, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 81 | 25489274 |
US |
67 | 2 |
Hospitalisation, Injection site pain, Injection site bruising, |
||||
DUPILUMAB, |
||||
| 82 | 25489577 |
US |
88 | |
Hospitalisation, |
||||
| 83 | 25489578 |
US |
2 | |
Hospitalisation, Product use in unapproved indication, |
||||
NIRAPARIB, NIRAPARIB, |
||||
| 84 | 25489580 |
US |
80 | 2 |
Hospitalisation, |
||||
POMALIDOMIDE, |
||||
| 85 | 25489635 |
JP |
69 | 2 |
Hospitalisation, Dysphagia, |
||||
PALIPERIDONE, |
||||
| 86 | 25489650 |
US |
79 | 1 |
Hospitalisation, Off label use, Therapy interrupted, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ACYCLOVIR, |
||||
| 87 | 25489709 |
US |
1 | |
Hospitalisation, |
||||
| 88 | 25489756 |
US |
2 | |
Hospitalisation, Off label use, |
||||
SUZETRIGINE, SUZETRIGINE, |
||||
| 89 | 25489841 |
US |
85 | 1 |
Hospitalisation, Skin ulcer, Product prescribing issue, |
||||
FOSTAMATINIB, |
||||
| 90 | 25489845 |
CA |
63 | 1 |
Spinal fracture, Adverse drug reaction, Fall, Inflammation, Pseudomonas infection, Respiration abnormal, Rib fracture, Injection site pain, Hospitalisation, |
||||
DUPILUMAB, DUPILUMAB, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, COLISTIMETHATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 91 | 25490467 |
US |
2 | |
Hospitalisation, |
||||
CANNABIDIOL, |
||||
| 92 | 25490603 |
JP |
9 | 2 |
Hospitalisation, |
||||
ROMOSOZUMAB-AQQG, ROMOSOZUMAB-AQQG, |
||||
| 93 | 25490805 |
US |
10 | 2 |
Pericarditis, Hospitalisation, Product use issue, Off label use, |
||||
VOCLOSPORIN, |
||||
| 94 | 25493939 |
46 | 1 | |
Hospitalisation, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, AMLODIPINE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 95 | 25493956 |
47 | 2 | |
Hospitalisation, Product dose omission issue, |
||||
| 96 | 25481153 |
US |
2 | |
Hospitalisation, Off label use, |
||||
AMIKACIN, |
||||
| 97 | 25481165 |
US |
1 | |
Hospitalisation, Therapy interrupted, |
||||
AMIKACIN, |
||||
| 98 | 25481375 |
US |
31 | 1 |
Hospitalisation, Diarrhoea, Drug effect less than expected, Product dose omission issue, |
||||
CANNABIDIOL, LAMOTRIGINE, FAMOTIDINE, ACETAMINOPHEN, IBUPROFEN, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, CLONAZEPAM, METHIMAZOLE, |
||||
| 99 | 25481422 |
US |
69 | 1 |
Hospitalisation, |
||||
POMALIDOMIDE, |
||||
| 100 | 25481577 |
FR |
1 | |
Hospitalisation, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29